Cognition Therapeutics, Inc.

NASDAQ:CGTX

0.4744 (USD) • At close November 4, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

20232022202120202019
Revenue 00000
Cost of Revenue 0.2520.2350.0930.0980.081
Gross Profit -0.252-0.235-0.093-0.098-0.081
Gross Profit Ratio 00000
Reseach & Development Expenses 37.19630.32418.57212.88714.379
General & Administrative Expenses 13.52813.22710.0264.523.452
Selling & Marketing Expenses -0.2520000
SG&A 13.52813.22710.0264.523.452
Other Expenses 0-22.217-17.447-10.855-13.164
Operating Expenses 25.76121.33411.1516.5524.667
Operating Income -50.724-43.551-28.598-17.407-17.831
Operating Income Ratio 00000
Total Other Income Expenses Net 24.93622.15416.8829.56812.989
Income Before Tax -25.788-21.397-11.716-7.839-4.842
Income Before Tax Ratio 00000
Income Tax Expense 0-22.154-1.4312.2332.111
Net Income -25.7880.757-10.285-10.072-6.953
Net Income Ratio 00000
EPS -0.860.026-0.46-0.46-0.32
EPS Diluted -0.860.026-0.46-0.46-0.32
EBITDA -50.628-21.134-13.382-5.972-3.499
EBITDA Ratio 00000